It's déjà vu all over again as Blue Cross and Blue Shield of Louisiana has hit pause on its plan to sell to Elevance Health for the second time within a year amid scrutiny from the state.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
Researchers explored data from nearly 17,000 U.S. heart transplant candidates, developing an updated model that ranks patients based on their mortality risk.